Garden Stage Limited GSIW
- Market cap
- $156.7M
- P/E
- —
Follow GSIW
Target Price Range
Analyst price targets
Free account| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | 840.00 | 103.80 | 17.00 | 8.00 |
Analyst estimates 2027–2029 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | 2,340.00 | 3,198.00 | 358.00 | 38.55 |
High Price
|
|||
| — | — | — | — | — | — | 12 | 17 | 17 | 20 |
Employees
|
|||
| — | — | — | — | — | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | 3 | 3 | 1 | 5 | 7 |
Revenue
|
|||
| — | — | — | — | — | 93.84% | 93.84% | 95.04% | 73.88% | 43.58% |
Gross Margin
|
|||
| — | — | — | — | — | 0 | (6) | (5) | (4) | (14) |
EBT
|
|||
| — | — | — | — | — | (6.37%) | 0.00% | (324.89%) | (78.20%) | (190.43%) |
EBT Margin
|
|||
| — | — | — | — | — | 0 | 0 | (5) | (4) | (14) |
Net Income
|
|||
| — | — | — | — | — | — | 0 | 0 | 0 | 1 |
Depreciation
|
|||
| — | — | — | — | — | 0.00 | 56.78 | 20.68 | 0.59 | 0.73 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | (0.30) | (60.18) | (0.47) | (1.38) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | (32.69) | (104.12) | (0.12) | (0.42) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | (0.39) | (0.02) | (0.02) | (0.01) |
Capex/Sh
|
|||
| — | — | — | — | — | — | (33.07) | (104.14) | (0.15) | (0.43) |
Free CF/Sh
|
|||
| — | — | — | — | — | 0.00 | 33.92 | 136.35 | 0.72 | 2.42 |
Book Value/Sh
|
|||
| — | — | — | — | — | — | 0 | 0 | 9 | 10 |
Shares
|
|||
| — | — | — | — | — | — | — | — | — | — | PE Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PS Ratio | |||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales
|
|||
| — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.69 | 1.73 |
EV/FCF
|
|||
| — | — | — | — | — | — | (2) | (7) | (1) | (4) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | 0 | 0 | 0 | 0 |
Capex
|
|||
| — | — | — | — | — | — | (2) | (7) | (1) | (4) |
FCF
|
|||
| — | — | — | — | — | 1 | 1 | 5 | 5 | 13 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | — | — | — | Total Debt | |||
| — | — | — | — | — | (6) | (6) | (9) | (8) | (18) |
Net Debt
|
|||
| — | — | — | — | — | 2 | 2 | 9 | 7 | 24 |
Sh' Equity
|
|||
| — | — | — | — | — | 0.00% | (65.58%) | (52.60%) | (26.58%) | (47.86%) |
ROA
|
|||
| — | — | — | — | — | 0.00% | 0.00% | (823.51%) | 0.00% | (129.93%) |
ROIC
|
|||
| — | — | — | — | — | 0.00% | 0.00% | (81.72%) | (54.01%) | (89.50%) |
ROE
|
|||
Garden Stage Limited peers in Capital Markets
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| NAKA KindlyMD, Inc. | $177.2M | 0.0× | Compare |
| BMHL Bluemount Holdings Limited | $130.4M | — | Compare |
| AUC ATIF Holdings Limited | $196.9M | 0.0× | Compare |
| DEFT DeFi Technologies Inc. | $205.7M | 8.3× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| FUFU BitFuFu Inc. | $210.0M | 0.0× | Compare |
| WTF Waton Financial Limited | $113.4M | — | Compare |
| AXG Solowin Holdings | $251.0M | — | Compare |
| SIEB Siebert Financial Corp. | $91.7M | 0.0× | Compare |
Garden Stage Limited (GSIW) key facts
- Garden Stage Limited (GSIW) is a Capital Markets company in the Financial sector, listed on Nasdaq.
- Garden Stage Limited’s revenue for fiscal 2026 (year ended March 2026) was $7.3 million, up 33.2% from fiscal 2025.
- As of September 25, 2026, GSIW traded at $14.04, a market capitalization of $156.7 million.
- Return on equity was −89.5% and debt-to-equity 0.00.
Garden Stage Limited (GSIW) Latest News
23 Mar
Garden Stage Limited (GSIW) regained compliance with Nasdaq's minimum bid price requirement, securing its continued listing on the exchange. Regaining Nasdaq compliance averts delisting risk, significantly enhancing stock liquidity and investor sentiment.
4 Mar
Garden Stage Limited (GSIW) announces a 200-for-1 consolidation of its Class A ordinary shares, effective after market close on the record date, to meet Nasdaq listing requirements. 200-for-1 share consolidation alters share structure and price appearance to comply with exchange rules, moderately impacting liquidity, investor sentiment, and short-term market performance.
11 Feb
Garden Stage Limited (GSIW) has announced a reclassification of its ordinary shares, which is expected to affect the structure of its equity. The company aims to enhance its capital structure and align with strategic goals. This move is part of a broader initiative to optimize shareholder value and improve market positioning. Reclassification of shares may influence investor sentiment and capital structure but is not expected to drastically alter the company's overall trajectory.
23 Oct
I Win Asset Management and eBroker Group Limited have entered into a strategic partnership agreement aimed at enhancing their service offerings and market reach. This collaboration is expected to leverage the strengths of both companies, potentially leading to improved financial performance and competitive positioning in the market. The partnership may moderately influence GSIW's competitive positioning and market sentiment.
12 Sep
Garden Stage Limited (GSIW) has been identified as one of the most active stocks in the market, reflecting heightened trading activity and interest among investors. This surge in activity may indicate potential shifts in investor sentiment or market dynamics surrounding the company. Analysts are closely monitoring GSIW's performance as it could signal broader trends within the industry. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.
28 Aug
Garden Stage Limited (GSIW) has been identified as one of the most active stocks in recent trading sessions, indicating heightened investor interest and trading volume. This activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance and investor sentiment moving forward. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.
25 Jul
Univest Securities, LLC has successfully closed a $4.2 million registered direct offering for Garden Stage Limited (NASDAQ: GSIW). This financing aims to support the company's growth initiatives and operational strategies. The capital raised may enhance Garden Stage Limited's financial performance and operational capabilities, but its overall impact is expected to be limited.
24 Jul
Garden Stage Limited (GSIW) has announced a registered direct offering of $4.2 million. The offering is expected to be completed shortly and will involve the sale of shares to a select group of institutional investors. Proceeds from the offering will be used for general corporate purposes, including potential expansion and operational enhancements. The offering may provide necessary capital for growth initiatives, but its overall impact on the company's trajectory is expected to be limited.
Garden Stage Limited (GSIW) has been identified as one of the most active stocks in the market, indicating heightened trading activity and investor interest. This surge in activity may reflect broader market trends or specific developments related to the company. Investors are closely monitoring GSIW's performance as it could signal potential opportunities or risks in the near future. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.
24 Jun
Garden Stage Limited (NASDAQ: GSIW) announced on June 23, 2025, that it has regained compliance with Nasdaq's minimum bid price requirement after previously receiving a notice of non-compliance on December 24, 2024. The company had been below the $1.00 per share threshold for 30 consecutive business days but successfully met the requirement within the 180-day compliance period. Regaining compliance with Nasdaq's listing requirements is expected to stabilize investor confidence and market perception.
16 Sep
Garden Stage Limited's subsidiaries, I Win Securities Limited and I Win Asset Management Limited, have entered into strategic cooperation agreements with Indicator Global Inc, a leading investment adviser in the US. The agreements cover various areas such as client introduction, derivatives, consulting, and possible joint venture. The cooperation agreements with Indicator Global Inc are expected to have a significant impact on Garden Stage Limited's future and market performance, potentially altering its trajectory and investor sentiment.
13 Sep
I Win Securities Limited, a subsidiary of Garden Stage Limited, is in advanced discussions with CICC and JPMorgan for distributing derivative products linked to A-share performance to Professional Investors. The potential distribution agreement with CICC and JPMorgan for derivative products could significantly impact Garden Stage Limited's future market performance and strategic positioning.
I Win Securities Limited and I Win Asset Management Limited, subsidiaries of Garden Stage Limited, have agreed on strategic initiatives with ZZC International (Group) Limited to collaborate on various financial topics. The cooperation agreement with ZZC is expected to have a significant impact on Garden Stage Limited's future and market performance by creating added business opportunities and expanding its reach.
1 Aug
Garden Stage (NASDAQ:GSIW) reported a net loss of US$4.59m for FY 2024, with a loss per share of US$0.34, significantly worse than FY 2023. The significant increase in net loss and loss per share for Garden Stage in FY 2024 is likely to have a major impact on its future performance and investor sentiment.
5 Dec
Garden Stage Limited closed its initial public offering of 2,500,000 ordinary shares at $4.00 per share, raising $11.5 million. The successful IPO and additional share purchase indicate a significant impact on the company's future growth and market performance.
1 Dec
Garden Stage Limited prices IPO at $4 per share on Nasdaq Capital Market. The IPO pricing and expected proceeds are significant for the company's future growth and market performance.